Hypera Pharma (HYPE3)
BOV
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
総売上 | 2.39B | 2.58B | 2.03B | 2.65B | 2.58B | 2.3B | 2.21B | 2.62B |
営業利益 | 684.03M | 686.62M | 535.8M | 734.13M | 735.84M | 512.03M | 579.4M | 687.18M |
税引前収入 | 442.13M | 440.84M | 270.02M | 471.84M | 474.34M | 293.28M | 373.81M | 470.17M |
純利益 | 469.68M | 431.74M | 339.42M | 504.39M | 497.94M | 309.37M | 391.55M | 491.8M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 684.03M | 686.62M | 535.8M | 734.13M | 735.84M | 512.03M | 579.4M | 687.18M |
EBITDA | 727.47M | 736.33M | 588.74M | 789.62M | 797.7M | 577.28M | 646.82M | 751.87M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
総売上 | 4.77B | 4.47B | 4.47B | 4.12B | 4.98B | 7.08B | 8.97B | 9.56B |
営業利益 | 1.83B | 950.6M | 1.22B | 1.05B | 1.28B | 1.53B | 2.47B | 2.52B |
税引前収入 | 1.61B | 998.26M | 1.22B | 1.06B | 1.21B | 1.21B | 1.6B | 1.51B |
純利益 | 1.17B | 964.94M | 1.13B | 1.16B | 1.3B | 1.33B | 1.7B | 1.65B |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 1.858 | 1.526 | 1.787 | 1.841 | 2.045 | 2.1 | 2.677 | 2.6 |
EBIT | 1.82B | 950.6M | 1.22B | 1.05B | 1.28B | 1.53B | 2.47B | 2.52B |
EBITDA | 1.86B | 1.03B | 1.31B | 1.14B | 1.4B | 1.67B | 2.64B | 2.75B |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約